Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Menopause can cause changes in your oral health. A dentist explains what changes you can expect from menopause and what you ...

If you've suddenly noticed that your gums feel tender or they bleed a little when you brush your teeth, a shift in hormones might be to blame—especially if you're a woman. As women go through life, a ...

Immunoglobulin 4-related disease (IgG4-RD) is known for its potential to affect nearly every organ, particularly a preference for large and middle-sized arteries when vascular involvement occurs.

Background: Sjögren’s disease (SjD) is an autoimmune disease marked by lymphocytic infiltration of salivary and lacrimal glands, leading to glandular dysfunction, where CD4-positive helper T (Th) ...

The thyroid gland is part of the endocrine system (along with the adrenal glands, hypothalamus, pituitary, ovaries, and testes, and other endocrine organs). The thyroid gland releases hormones into ...

The drug, Orlynvah, has been approved to treat uncomplicated UTIs in women who have limited oral antibacterial treatment options or none at all. UTI is a common bacterial infection of the bladder ...

The need for treatment alternatives for salivary gland infections is mostly driven by the rising prevalence of infections, especially bacterial, fungal, and viral infections. The prevalence of ...